Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Becoming amazing at Systems administration: Individual and Expert Tips - 225 Years Ago, Audi's Rosemeyer Concept Was A Steampunk Supercar With A Massive Engine
- 3James Webb Space Telescope watches our Milky Way galaxy's monster black hole fire out a flare
- 4Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- 5Medicine doesn’t just have ‘conscientious objectors’ − there are ‘conscientious providers,’ too
- Most loved Public Dish: Which One Addresses Its Nation Best?
- Compassion and Association: Building Significant Connections
- The Best 15 Applications for Efficiency and Association
- 6 Hints to Upgrade Your Appeal, In addition to Your Outlook
- Moderna to complete US mRNA manufacturing network with $140 million investment
- Visual communication Programming for Fledglings
- Doctors looking into hormone therapy as a way to ward off dementia in women
- Favored Chinese Dish: Make Your Determination
- What's the Fate of 5G Innovation?
